Erschienen in:
13.04.2019 | Letter
Underpowered or negative? A crucial distinction. Reply to Dollerup OL, Treebak JT, Jessen N [letter]
verfasst von:
Niels J. Connell, Riekelt H. Houtkooper, Patrick Schrauwen
Erschienen in:
Diabetologia
|
Ausgabe 6/2019
Einloggen, um Zugang zu erhalten
Excerpt
To the Editor: Jessen and colleagues [
1] have commented on our recent review of NAD
+ metabolism in
Diabetologia [
2]. In their letter, they comment on the discussion and citation of a clinical trial that they performed, in which dietary nicotinamide riboside was supplemented in obese men to assess the effects on whole body insulin sensitivity [
3]. …